Literature DB >> 7039874

Prostaglandin-dependent regulation of the in vitro proliferative response to mycobacterial antigens of peripheral blood lymphocytes from normal donors and from patients with tuberculosis or leprosy.

G M Bahr, G A Rook, J L Stanford.   

Abstract

The response to soluble mycobacterial antigens of peripheral blood mononuclear cells, from most normal donors, tuberculosis patients or cases of tuberculoid leprosy (TT/BT) was enhanced by the addition of indomethacin. In contrast, indomethacin caused no enhancement of the response of cells from lepromatous leprosy (BL/LL) cases. Moreover the addition of 10-5 M prostaglandin E2 (PGE2) failed to inhibit the proliferative responses of cells from the BL/LL patients, although it markedly inhibited the responses of peripheral blood mononuclear cells from the other groups. The addition of PGE2 or indomethacin to cells which had been precultured for 48 hr had no significant effect on the proliferative responses of cells from any of the groups of donors. These results suggest that a normal, prostaglandin-dependent, indomethacin-sensitive regulatory mechanism is absent from the peripheral blood mononuclear cells of BL/LL patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7039874      PMCID: PMC1537408     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Cell suppression in PPD-induced blast specific response of human peripheral blood lymphocytes.

Authors:  C Bona; F Audibert; D Juy; L Chedid
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

2.  Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy.

Authors:  B Myrvang; T Godal; D S Ridley; S S Fröland; Y K Song
Journal:  Clin Exp Immunol       Date:  1973-08       Impact factor: 4.330

Review 3.  Modulation of inflammation and immunity by cyclic AMP.

Authors:  H R Bourne; L M Lichtenstein; K L Melmon; C S Henney; Y Weinstein; G M Shearer
Journal:  Science       Date:  1974-04-05       Impact factor: 47.728

Review 4.  Immunological phenomena in leprosy and related diseases.

Authors:  J L Turk; A D Bryceson
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

5.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

6.  Multiple skin testing in leprosy.

Authors:  R C Paul; J L Stanford; J W Carswell
Journal:  J Hyg (Lond)       Date:  1975-08

7.  The effects of cyclic AMP on leucocyte inhibitory factor (LIF) production and on the inhibition of leucocyte migration.

Authors:  R Lomnitzer; A R Rabson; H J Koornhof
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

8.  Release of prostaglandin by mitogen- and antigen-stimulated leukocytes in culture.

Authors:  V A Ferraris; F R DeRubertis
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

9.  Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses.

Authors:  I Nath; J J Van Rood; N K Mehra; M C Vaidya
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

10.  Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.

Authors:  L Shou; S A Schwartz; R A Good
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  5 in total

1.  Regulation of macrophage accessory cell activity by mycobacteria. II. In vitro inhibition of Ia expression by Mycobacterium microti.

Authors:  P M Kaye; M Sims; M Feldmann
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

2.  Prostaglandin E2 down-regulates viable Bacille Calmette-Guérin-induced macrophage cytotoxicity against murine bladder cancer cell MBT-2 in vitro.

Authors:  H Yamada; E Kuroda; S Matsumoto; T Matsumoto; T Yamada; U Yamashita
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

3.  Demonstration of an indomethacin-sensitive mechanism regulating immune reactivity in American cutaneous leishmaniasis patients.

Authors:  M Castes; D Trujillo; D Scott; A J Rondon
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

Review 4.  Host Lipid Mediators in Leprosy: The Hypothesized Contributions to Pathogenesis.

Authors:  Carlos A M Silva; John T Belisle
Journal:  Front Immunol       Date:  2018-02-02       Impact factor: 7.561

5.  PGE2 displays immunosuppressive effects during human active tuberculosis.

Authors:  Joaquín Miguel Pellegrini; Candela Martin; María Paula Morelli; Julieta Aylen Schander; Nancy Liliana Tateosian; Nicolás Oscar Amiano; Agustín Rollandelli; Domingo Juan Palmero; Alberto Levi; Lorena Ciallella; María Isabel Colombo; Verónica Edith García
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.